reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Lunai Bioworks Inc.

LNAI · Nasdaq

1 reporting failure in the last 12 months

Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.

$21Mpublic float
2026-09-29most recent failure
2025-02-19declared past accounts unreliable
2024-08-19declared past accounts unreliable

Score over time

01234202220232024202520262022-10-01 · score 12022-09-29 filed late (10-K) · complex accounting2023-01-01 · score 22022-11-15 filed late (10-Q) · complex accounting2022-09-29 filed late (10-K) · complex accounting2023-04-01 · score 22022-11-15 filed late (10-Q) · complex accounting2022-09-29 filed late (10-K) · complex accounting2023-07-01 · score 22022-11-15 filed late (10-Q) · complex accounting2022-09-29 filed late (10-K) · complex accounting2023-10-01 · score 22023-09-29 filed late (10-K) · complex accounting2022-11-15 filed late (10-Q) · complex accounting2024-01-01 · score 12023-09-29 filed late (10-K) · complex accounting2024-04-01 · score 12023-09-29 filed late (10-K) · complex accounting2024-07-01 · score 12023-09-29 filed late (10-K) · complex accounting2024-10-01 · score 12024-08-19 accounts unreliable2025-01-01 · score 22024-10-01 filed late (10-K) · accounts not ready2024-08-19 accounts unreliable2025-04-01 · score 42025-02-19 accounts unreliable2025-02-18 filed late (10-Q) · accounts not ready2024-10-01 filed late (10-K) · accounts not ready2024-08-19 accounts unreliable2025-07-01 · score 42025-02-19 accounts unreliable2025-02-18 filed late (10-Q) · accounts not ready2024-10-01 filed late (10-K) · accounts not ready2024-08-19 accounts unreliable2025-10-01 · score 32025-02-19 accounts unreliable2025-02-18 filed late (10-Q) · accounts not ready2024-10-01 filed late (10-K) · accounts not ready2026-01-01 · score 22025-02-19 accounts unreliable2025-02-18 filed late (10-Q) · accounts not ready2026-10-01 · score 12026-09-29 filed late (10-K)

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Lunai Bioworks Inc. (the “Company”) is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 (the “Form 10-K”) within the prescribed time period. The Company anticipates that it will file the Form 10-K on or before the fifteenth calendar day following the prescribed due date, as permitted by Rule 12b-25(b)

NT 10-K, filed 2026-09-29

What it filed

2026-09-29filed late (10-K) SEC →

Lunai Bioworks Inc. (the “Company”) is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 (the “Form 10-K”) within the prescribed time period. The Company anticipates that it will file the Form 10-K on or before the fifteenth calendar day following the prescribed due date, as permitted by Rule 12b-25(b)

2025-02-19accounts declared unreliable SEC →

2025-02-18filed late (10-Q)accounts not ready SEC →

Renovaro Inc., a Delaware corporation (the “ Company ”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended December 31, 2024 (the “ Form 10-Q ”). The Company could not complete the filing of its Form 10-Q within the prescribed time period without unreasonable effort or expense because additional time is needed to finalize the financial statements to be included in such report, particularly related to the settled equity and the total outstanding equity as of December 31, 2024.The Registrant anticipates that it will file its Form 10-Q within the five-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended

2024-10-01filed late (10-K)accounts not ready SEC →

Renovaro Inc., a Delaware corporation (the “ Company ”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended June 30, 2023 (the “ Form 10-K ”). The Company could not complete the filing of its Annual Report on Form 10-K for the period ended June 30, 2024, within the prescribed time period without unreasonable effort or expense because additional time is needed to finalize the financial statements to be included in such report. The Registrant anticipates that it will file its Form 10-K within the fifteen-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended

2024-08-19accounts declared unreliable SEC →

2023-09-29filed late (10-K)complex accounting SEC →

Renovaro Biosciences Inc., a Delaware corporation (the “ Company ”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended June 30, 2023 (the “ Form 10-K ”). The Company could not complete the filing of its Annual Report on Form 10-K for the period ended June 30, 2023, due to a delay in obtaining and compiling information required to be included in the Company’s Form 10-K, which delay could not be eliminated by the Company without unreasonable effort and expense. In particular, certain third-party valuation work could not be completed prior to the filing date. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company will file its Form 10-K no later than the fifteenth calendar day following the prescribed due date

2022-11-15filed late (10-Q)complex accounting SEC →

Enochian Biosciences Inc., a Delaware corporation (the “ Company ”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (the “ Form 10-Q ”). The Company could not complete the filing of its Quarterly Report on Form 10-Q for the period ended September 30, 2022, due to a delay in obtaining and compiling information required to be included in the Company’s Form 10-Q, which delay could not be eliminated by the Company without unreasonable effort and expense. In particular, certain third-party valuation work could not be completed prior to the filing date

2022-09-29filed late (10-K)complex accounting SEC →

Enochian Biosciences Inc., a Delaware corporation (the “ Company ”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended June 30, 2022 (the “ Form 10-K ”). The Company could not complete the filing of its Annual Report on Form 10-K for the period ended June 30, 2022, due to a delay in obtaining and compiling information required to be included in the Company’s Form 10-K, which delay could not be eliminated by the Company without unreasonable effort and expense. In particular, certain third-party valuation work could not be completed prior to the filing date. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company will file its Form 10-K no later than the fifteenth calendar day following the prescribed due date

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com